The firm expects to save more than $35 million in annualized costs through the restructuring. CEO Anne Wojcicki told ...

What is the most Silicon Valley thing about your morning routine? Zoë, you go first. Zoë Schiffer: Pretty much the first ...

Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.

The restructuring arrives during a period of turmoil at California-based 23andMe, which has recently included a high-profile ...

CEO Anne Wojcicki described the layoffs as “difficult but necessary” to ensure 23andMe’s long-term survival. The cuts, ...

Me is to cut 200 jobs in the wake of declining revenues. This company expects a proposed retructuring, affecting 40% of its ...

Anne Wojcicki, 23andMe’s co-founder and chief executive, has said she intends to take the company private and will not consider a third-party takeover. “We are committed to protecting customer data ...

CEO Anne Wojcicki has said she intends to take the company private and is not considering third-party takeover proposals. Customer data collected from its genetic testing tools makes up the company's ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0616 GMT – Mega Lifesciences is facing pressure from a ...

Meanwhile, Hims & Hers tackles the GLP-1 shortage with a new app; Eli Lilly releases data on tirzepatide efficacy; 23andMe faces privacy concerns; and more.

Last June marked four years since the release of Deloitte Canada's inaugural Reconciliation Action Plan (RAP), the first ...